- Home
- GROW vs DYAI Comparison
GROW vs DYAI Comparison
Compare GROW & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROW | DYAI |
|---|---|---|
| Founded | 1968 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 29.9M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | GROW | DYAI |
|---|---|---|
| Price | $2.49 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 34.4K | ★ 116.0K |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $8,546,000.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | N/A | $92.04 |
| P/E Ratio | $37.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.02 | $0.71 |
| 52 Week High | $2.78 | $2.14 |
Technical Indicators
Market Signals| Indicator | GROW | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 55.29 | 52.70 |
| Support Level | $2.45 | $0.90 |
| Resistance Level | $2.55 | $0.99 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 64.86 | 67.61 |
Price Performance
Historical ComparisonAbout GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.